Back
Virtus LifeSci Biotech Clinical Trls ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison
Sell
50
BBC
Virtus LifeSci Biotech Clinical Trls ETF
Last Price:
29.89
Seasonality Move:
6.7%
Sell
49
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
29.16
Seasonality Move:
4.52%
Sell
50
Virtus LifeSci Biotech Clinical Trls ETF (BBC)
is a Sell
Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $29.28. The Score for BBC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.56. The Score for FTXH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BBC Stock Price Chart
What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?
-
The Virtus LifeSci Biotech Clinical Trls ETF share price today is $29.28
The current trend is moderately bullish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.
BBC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 48.3 | Sell |
Chaikin Money Flow: | -2962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.8 - 30.48) | Sell |
Bollinger Bands (100): | (26.45 - 29.55) | Buy |
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 49.28 | Sell |
Chaikin Money Flow: | -3055 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.21 - 28.85) | Buy |
Bollinger Bands (100): | (27.89 - 29.17) | Buy |
BBC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.2 | Sell |
20-day SMA: | 29.77 | Sell |
50-day SMA: | 28.82 | Buy |
200-day SMA: | 27.78 | Buy |
8-day EMA: | 30.02 | Sell |
20-day EMA: | 29.69 | Sell |
50-day EMA: | 28.98 | Buy |
200-day EMA: | 27.29 | Buy |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.67 | Sell |
20-day SMA: | 28.48 | Buy |
50-day SMA: | 28.71 | Sell |
200-day SMA: | 27.83 | Buy |
8-day EMA: | 28.68 | Sell |
20-day EMA: | 28.59 | Sell |
50-day EMA: | 28.6 | Sell |
200-day EMA: | 27.9 | Buy |
Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |